Hi-Tech Pharmacal Reports Sales Of $59.9 Million For The Third Quarter Ended January 31, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today reported results for the third fiscal quarter ended January 31, 2014.

•Net sales of $59.9 million for the third quarter compared to $64.3 million for the same prior year period •GAAP income of $8.4 million or $0.59 per diluted share for the third quarter

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC